Completed PHASE4 INTERVENTIONAL 2-arm NCT02286752

Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting.

Sponsor: Ordu University

Conditions Incidence of Postoperative Nausea and Vomiting

Updated 7 times since 2017 Last updated: Jan 11, 2015 Started: Jun 30, 2014 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02286752, this PHASE4 trial focuses on Incidence of Postoperative Nausea and Vomiting and remains completed. Sponsored by Ordu University, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Nov 2025 — Present [monthly]

Completed PHASE4
Sep 2025 — Nov 2025 [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ordu University

Data source: Ordu University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Altinordu, Turkey (Türkiye)